Literature DB >> 14559404

Prostanoid receptor signaling relevant to tumor growth and angiogenesis.

Masataka Majima1, Hideki Amano, Izumi Hayashi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559404     DOI: 10.1016/j.tips.2003.08.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  17 in total

1.  Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.

Authors:  Arun George Paul; Neelam Sharma-Walia; Nagaraj Kerur; Carl White; Bala Chandran
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

2.  PPAR-gamma is expressed and NF-kB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas.

Authors:  Gerasimos P Vandoros; Panagiotis A Konstantinopoulos; Georgia Sotiropoulou-Bonikou; Athina Kominea; Georgios I Papachristou; Michalis V Karamouzis; Maria Gkermpesi; Ioannis Varakis; Athanasios G Papavassiliou
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-08       Impact factor: 4.553

3.  COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.

Authors:  Hiroshi Katoh; Kanako Hosono; Yoshiya Ito; Tatsunori Suzuki; Yasufumi Ogawa; Hidefumi Kubo; Hiroki Kamata; Toshiaki Mishima; Hideaki Tamaki; Hiroyuki Sakagami; Yukihiko Sugimoto; Shuh Narumiya; Masahiko Watanabe; Masataka Majima
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

4.  Recruitment of a prostaglandin E receptor subtype, EP3-expressing bone marrow cells is crucial in wound-induced angiogenesis.

Authors:  Emi Kamoshita; Yasuhiro Ikeda; Mamoru Fujita; Hideki Amano; Atsuhiko Oikawa; Tastunori Suzuki; Yasuhumi Ogawa; Shohei Yamashina; Sadahiro Azuma; Shuh Narumiya; Nobuya Unno; Masataka Majima
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

5.  Effect of c-fos antisense probe on prostaglandin E2-induced upregulation of vascular endothelial growth factor mRNA in human liver cancer cells.

Authors:  Yong-Qi Li; Kai-Shan Tao; Ning Ren; Yi-Hu Wang
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

6.  Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-03-20       Impact factor: 7.012

Review 7.  Prostanoid receptor antagonists: development strategies and therapeutic applications.

Authors:  R L Jones; M A Giembycz; D F Woodward
Journal:  Br J Pharmacol       Date:  2009-07-15       Impact factor: 8.739

8.  Vascular endothelial growth factor receptor 1 signaling facilitates gastric ulcer healing and angiogenesis through the upregulation of epidermal growth factor expression on VEGFR1+CXCR4 + cells recruited from bone marrow.

Authors:  Takehito Sato; Hideki Amano; Yoshiya Ito; Koji Eshima; Tsutomu Minamino; Takako Ae; Chikatoshi Katada; Takashi Ohno; Kanako Hosono; Tatsunori Suzuki; Masabumi Shibuya; Wasaburo Koizumi; Masataka Majima
Journal:  J Gastroenterol       Date:  2013-08-24       Impact factor: 7.527

9.  Tumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets.

Authors:  Ninib Baryawno; Baldur Sveinbjörnsson; Staffan Eksborg; Abiel Orrego; Lova Segerström; Carl Otto Oqvist; Stefan Holm; Bengt Gustavsson; Bertil Kågedal; Per Kogner; John Inge Johnsen
Journal:  Neuro Oncol       Date:  2008-08-20       Impact factor: 12.300

10.  Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation.

Authors:  Jianxiong Jiang; Ray Dingledine
Journal:  J Pharmacol Exp Ther       Date:  2012-11-28       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.